|
2012 Conference Schedule
Current Trends in Cardiovascular Disease XIV
April 14, 2012
Spokane Convention Center
334 W Spokane Falls Blvd, Spokane, WA
7:00 am-8:00 am – Registration, Continental Breakfast, Visit Exhibitors
8:00 am Introduction - Guy E Katz MD FACC Program Director
Session 1: Challenges In Screening and Treatments
8:15 am-8:45 am - Chest Pain and Syncope in the Pre Adolescent
C. Chris Anderson, MD - Northwest Pediatric Cardiology
-
Apply risk stratification concepts to clinical scenarios
- Choose the proper diagnostic cardiac testing
- Refer children appropriately to a Cardiologist?
8:45 am-9:15 am Cardiac Biomarkers – Pearls and Pitfalls of Use
Pierre Leimgruber MD FACC – Providence Spokane Heart Institute
- Understand diagnostic and prognostic value
- Recognize causes for false positive test results
- Treating “test results”
9:15 am-9:45 am Mazes in Lipid Management – Choices and Challenges
Bryan Fuhs MD FACC – Providence Spokane Heart Institute
- Review current guidelines for Secondary Prevention
- Discuss challenges to achieving guidelines; New Warnings
- Treatment Pearls for improved outcomes
9:45 am-10:15 am Cardiac Diagnosis in Women: Approaches to Clinical Scenarios
Janice Christensen MD FACC Providence Spokane Heart Institute
- Review clinical presentations of cardiac problems in women
- Discuss differential diagnosis and testing options
Morning Break 10:15-10:45
Session 2: Challenges in Congestive Heart Failure
10:45 am-11:15 am - Heart Failure with Preserved LV Function - A growing Epidemic
Andrew Boulet MD FACC – Providence Spokane Heart Institute
- Pathophysiology of HFpER and Clinical Recognition
- Discuss different therapeutic options vs Systolic Heart Failure
- Prognostic considerations – Can they be modified with treatment
11:15 am-11:45 am- Device Therapy for CHF: AICD and Biventricular Pacing
Gerhard Muelheims MD FACC – Providence Spokane Heart Institute
- Understand patient subsets for which device therapy may benefit
- Primary Care Issues for patients with Cardiac Resynchronization Therapy (CRT) and Automatic Implantable Cardiac Defibrillators (AICD) –
11:45 am-12:15 pm - “Failure in Treating Heart Failure” Evolving Role for Mechanical Support Devices
Andrew Coletti MD FACC – PeaceHealth Medical Group
- Review ACC stages of heart failure with particular focus on identifying patients with ACC stage D heart failure
- Review indications for advanced heart failure therapies- ie. Left VAD, total artificial heart, and cardiac transplantation.
- Review the role of the multidisciplinary advanced heart failure team in caring for patients with Stage D heart failure.
12:15-1:00 PM Buffet Lunch and Visit Exhibits
Session 3: Clots and Clogging
1:00 pm-1:15 pm - Medical Therapy for “Clots”– New Antiplatelet and Antithrombotic Treatment
Dieter Lubbe MD, FACC– Providence Spokane Heart Institute
- Antiplatelet Therapy Options – Current and Future
- Recognition of the “non responders”- Clinical implications
- Newer Anticoagulation Options
1:15 pm-1:45 pm - Atrial Emboli – New Treatment Options for PFO and Atrial Appendages
Philip Huber MD FACC – Providence Spokane Heart Institute
- Patent Foramen Ovale – Indications for Intervention
- Atrial Appendage Thrombi – Role for Occlusion Devices
1:45 pm – 2:15 pm - The Initial Evaluation of Arterial and Venous Insufficiency-Practical Screening and Treatment
Joe Davis MD – Inland Vascular Institute
- Review the differential diagnosis and evaluation of patients presenting in an office setting with PAD (Spectrum from asymptomatic-claudication-critical ischemia)
- Review exercise, pharmacologic, endovascular and surgical options for treatment
- Proper recognition of patients with venous insufficiency and treatment options
2:30 -2:50 PM Refreshment Break and Visit Exhibits
Session 4: Evolving Treatments in Valvular Heart Disease
2:50 pm – 3:20 pm - Interventional Cardiology – New Frontiers
Susan Alexander MD FACC – Providence Spokane Heart Institute
- Analyze the treatment limitations for certain cardiac and vascular problems.
- Assess the recent scientific presentations of novel and evolving technologies for percutaneous treatment options
3:20 pm – 3:50 pm
-
Transcatheter Aortic Valve Replacements
Michael Ring MD FACC – Providence Spokane Heart Institute
Branden Reynolds MD – NW Heart & Lung Surgical Associates
- Evaluate new percutaneous treatments for valvular heart disease
- Considerations for patient selection
- What are “good outcomes” for a “high risk patient”?
3:50 pm - 4 pm - Closing remarks, survey collection, and CME certificates |